Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis

Published:2016-10-28 Issue:2 Volume:31 Page:213-220
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Puig L.¹,Thom H.²,Mollon P.³,Tian H.⁴,Ramakrishna G.S.⁵

Affiliation:

1. Department of Dermatology; Hospital de la Santa Creu i Sant Pau; Universitat Autonoma de Barcelona Medical School; Barcelona Spain

2. School of Social and Community Medicine; University of Bristol; Bristol UK

3. Global Patient Access; Novartis Pharma AG; Basel Switzerland

4. Global Medical Affairs; Novartis Pharmaceuticals Corporation; One Health Plaza East Hanover NJ USA

5. Patient Access Services; Novartis Healthcare Private Limited; Hyderabad India

Funder

Novartis Pharma

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.14007/fullpdf

Reference31 articles.

1. Effect of biologic agents on non-PASI outcomes in moderate to severe plaque psoriasis: systematic review and meta-analyses;Baker;Dermatol Ther,2012

2. Comorbidities in dermatology;Wakee;Dermatol Clin,2009

3. The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms;Wahl;J Am Acad Dermatol,2000

4. Suicidal ideation in psoriasis;Gupta;Int J Dermatol,1993

5. Psoriasis causes as much disability as other major medical diseases;Rapp;J Am Acad Dermatol,1999

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients with Persistent Mild Psoriasis after Treatment with Ustekinumab Achieved Greater Improvements in Skin Clearance and Patient-reported Outcomes after Switching to Guselkumab in the Phase 3 NAVIGATE Trial;Acta Dermato-Venereologica;2024-09-05

2. Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial;Dermatology and Therapy;2024-08-17

3. Health-Related Quality of Life in Psoriasis: Literature Review;Journal of Clinical Medicine;2024-08-07

4. Assessing the methodological quality and risk of bias of systematic reviews: primer for authors of overviews of systematic reviews;BMJ Medicine;2024-05

5. Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60;Dermatology and Therapy;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3